Proven combination vaccine that offers broad protection for dogs against common vaccine strains.
CANINE 1-DAPPV+CV PROVIDES PROTECTION AGAINST A COMBINATION OF VIRUSES.
Canine Distemper Virus, Canine Adenovirus 2, Canine Parainfluenza Virus, Canine Parvovirus (modified live viruses), Coronavirus (inactivated virus).
- Protects against all known strains of canine parvovirus (CPV), including CPV-2c1-3
- Contains CPV-2b, one of the most prevalent field strains of parvovirus
- High antigenic mass (titer), low passage parvovirus vaccine
- Overrides maternal antibodies in young puppies1
- Protects against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs
- Provides disease coverage for commonly spread canine viruses, coronavirus, distemper, adenovirus types 1 and 2, parainfluenza and parvovirus, in 1 formula
Approved for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper, adenovirus types 1 and 2, parainfluenza, parvovirus, and coronavirus.
Recommended for use in healthy dogs 6 weeks of age or older.
ADMINISTRATION AND DOSAGE
- Subcutaneous or intramuscular injection
- Two 1 mL doses given 2-4 weeks apart
- Repeat at 2-4 week intervals until the dog is 12 weeks of age
- Annual revaccination with 1 dose is recommended: Following the advice of The American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be based upon veterinarian-client patient relationships
- Available in a 25 x 1 mL dose presentation
ALSO AVAILABLE IN OTHER FORMULATIONS
Professional Resources and Educational Materials
Keep your clinic and staff informed and aware of diseases and outbreaks.
In-depth information about canine vaccinations and veterinary best practices.
Use these ready-to-share posts to educate pet parents and drive business to your clinic for preventative care.
A handy guide to protect dogs and prevent the spread of leptospirosis.
No items to show.
1. Data on file, Merck Animal Health.
2. Larson LJ, Schultz RD. Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant? Vet Ther. 2008;9(2):94–101.
3. Schultz RD, Thiel B, Mukhtar E, Sharp P, Larson LJ. Age and long-term protective immunity in dogs and cats. J Comp Pathol. 2010;142 Suppl 1:S102–S108.